Table 3.
Groups | AST (U/ml) | ALT (U/ml) | ||
24 h | 72 hs | 24 h | 72 hs | |
Infected untreated group | 156.8 ± 8.37 | 147.6 ± 2.15 | 112 ± 1.64 | 112.4 ± 4.13 |
AMB group | 73.4 ± 5.48a | 85.8 ± 4.56a | 87.4 ± 2.83a | 85.2 ± 9.47a |
IE group | 87.4 ± 7.97a | 92.2 ± 3.96ab | 65.2 ± 3.42a | 68.4 ± 12.86a |
IE + AMB group | 70.6 ± 7.31a | 64.8 ± 10.37a | 91 ± 8.34 | 93 ± 5.87 |
ANOVA Two way | ||||
Treatment | p<0.0001 | p<0.0001 | ||
Time | NS | NS | ||
Interaction | p<0.01 | NS | ||
(treatment X time intervals) |
Data are presented as mean ± SEM (n=5 in each group).
Significantly different from infected untreated group at p<0.05.
Significantly different from AMB treated group at p<0.05.